EDGEWOOD, Md., Jan. 29, 2015 /PRNewswire/ -- Nutramax
Laboratories® announced today the publication of results
from an international clinical study that demonstrates the
effectiveness of glucosamine hydrochloride and chondroitin sulfate
– the same active ingredients found in the joint health dietary
supplement Cosamin®DS -- in the management of joint health and
wellness. The results of the MOVES (Multicentre Osteoarthritis
InterVEntion trial with Sysadoa) study are published in the online
edition of the peer-reviewed journal, Annals of the Rheumatic
Diseases.
MOVES is a multicenter, randomized, parallel-group,
double-blind, controlled clinical trial that enrolled 606 patients
at 42 centers in France,
Germany, Poland and Spain. Sponsored by Bioiberica, suppliers of
the chondroitin sulfate used in Cosamin®DS. The study
was developed as an extension of the GAIT
(Glucosamine/Chondroitin Arthritis Intervention Trial) study,
which showed that the combination of glucosamine hydrochloride
(1,500 mg/day) and chondroitin sulfate (1,200 mg/day) was effective
in a moderate to severe subgroup of patients.
"The MOVES trial is truly an important study that provides
additional evidence to support the use of glucosamine hydrochloride
and chondroitin sulfate, at a daily dose of 1,500 and 1,200
milligrams, respectively, in managing joint health in a wide
variety of patient populations," said Dr. Nicholas DiNubile, M.D., clinical associate in
the Department of Orthopedic Surgery at the Hospital of the
University of Pennsylvania. "This new
data is especially encouraging for patients, and it reinforces my
ongoing approach to long-term joint health management in my
practice, particularly for people who are experiencing a
significant increase in the incidence of deteriorating joint health
yet wish to remain physically active."
Manufactured in Edgewood, MD,
Cosamin®DS is the most researched
glucosamine/chondroitin joint health supplement(1).
Cosamin®DS uses FCHG49® glucosamine and
TRH122® chondroitin sulfate, providing a unique
combination of ingredients not found in other
glucosamine/chondroitin combination dietary supplements. "I
tell my patients, not all supplements are created equal –
Brand Matters! It's important to
recommend supplements supported by extensive research like
Cosamin®," said Dr. Nicholas
DiNubile, M.D.
"We were the first company to develop this combination worldwide
and publish clinical studies showing its benefits for joint
health. We have been conducting both Human and Veterinary
research for over 20 years, so it's gratifying to see studies of
this magnitude that confirm our previous findings. The MOVES
study further underscores the value of Cosamin®DS as a
safe and effective option to support joint health," said
Pharmacist Robert Henderson, Chairman and Founder of Nutramax
Laboratories®.
About the Nutramax Laboratories Family of
Companies:
Since 1992, Christian-based Nutramax Laboratories has been
developing products for people and their pets. Nutramax
Laboratories Consumer Care, Inc., located in Edgewood, Maryland, focuses on researching and
developing products to promote consumer health. Located in
Lancaster, South Carolina,
Nutramax Laboratories Veterinary Sciences, Inc. researches and
develops high quality products to support animal health. Nutramax
Manufacturing, Inc. manufactures products in both the Maryland and South
Carolina locations.
Cosamin® joint health supplements, including the
original Cosamin®DS and advanced formula
Cosamin®ASU, are available in the U.S. to help support
and promote joint health.
(1) Based on published studies in
peer-reviewed journals, Cosamin®is the most
researched glucosamine/chondroitin brand.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/landmark-clinical-study-confirms-effectiveness-of-glucosamine-hydrochloride-and-chondroitin-sulfate-combination-in-supporting-joint-health-300027822.html
SOURCE Nutramax Laboratories